MBB Public Markets I LLC Makes New Investment in HCA Healthcare, Inc. $HCA

Key Points

• MBB Public Markets I LLC has acquired a new stake in HCA Healthcare, purchasing 952 shares valued at approximately $329,000 in the first quarter.
• HCA Healthcare announced a quarterly dividend of $0.72 per share, reflecting an annualized yield of 0.7%, with the dividend set to be paid on September 30th.
• Multiple analysts have raised their target prices for HCA Healthcare, with a consensus target price of $401.83, indicating a generally positive outlook on the stock's performance.

MBB Public Markets I LLC bought a new position in shares of HCA Healthcare, Inc. (NYSE:HCA - Free Report) in the first quarter, according to the company in its most recent filing with the SEC. The institutional investor bought 952 shares of the company's stock, valued at approximately $329,000.

Other hedge funds also recently modified their holdings of the company. Cheviot Value Management LLC bought a new position in shares of HCA Healthcare in the 1st quarter valued at about $26,000. Saudi Central Bank bought a new position in shares of HCA Healthcare in the 1st quarter valued at about $26,000. WPG Advisers LLC bought a new position in shares of HCA Healthcare in the 1st quarter valued at about $27,000. Atwood & Palmer Inc. bought a new position in HCA Healthcare during the first quarter worth about $28,000. Finally, Bartlett & CO. Wealth Management LLC grew its holdings in HCA Healthcare by 888.9% during the first quarter. Bartlett & CO. Wealth Management LLC now owns 89 shares of the company's stock worth $31,000 after purchasing an additional 80 shares during the period. Institutional investors own 62.73% of the company's stock.

Analyst Ratings Changes

A number of equities analysts recently commented on the company. Wells Fargo & Company reduced their price target on HCA Healthcare from $385.00 to $375.00 and set an "equal weight" rating for the company in a report on Thursday, August 14th. Truist Financial lifted their price target on HCA Healthcare from $390.00 to $415.00 and gave the stock a "buy" rating in a report on Wednesday, July 16th. Wolfe Research cut HCA Healthcare from an "outperform" rating to a "peer perform" rating in a report on Monday, July 28th. Cantor Fitzgerald restated an "overweight" rating and set a $444.00 price objective on shares of HCA Healthcare in a research report on Tuesday, August 26th. Finally, Morgan Stanley dropped their price target on shares of HCA Healthcare from $410.00 to $400.00 and set an "equal weight" rating for the company in a research report on Monday, July 28th. One equities research analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating and nine have given a Hold rating to the company. According to data from MarketBeat, the stock has an average rating of "Moderate Buy" and an average target price of $403.17.

Insider Buying and Selling at HCA Healthcare

In other HCA Healthcare news, EVP Michael S. Cuffe sold 3,836 shares of the business's stock in a transaction on Monday, September 8th. The shares were sold at an average price of $418.84, for a total transaction of $1,606,670.24. Following the sale, the executive vice president owned 31,503 shares of the company's stock, valued at approximately $13,194,716.52. The trade was a 10.85% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Insiders own 1.30% of the company's stock.

HCA Healthcare Price Performance

HCA traded up $2.69 during trading on Friday, hitting $405.54. 761,184 shares of the stock traded hands, compared to its average volume of 1,129,364. HCA Healthcare, Inc. has a twelve month low of $289.98 and a twelve month high of $420.98. The company has a market cap of $94.89 billion, a price-to-earnings ratio of 17.05, a PEG ratio of 1.27 and a beta of 1.41. The company has a debt-to-equity ratio of 69.07, a current ratio of 0.98 and a quick ratio of 0.86. The business has a 50 day moving average price of $382.88 and a 200 day moving average price of $362.77.

HCA Healthcare (NYSE:HCA - Get Free Report) last announced its quarterly earnings data on Friday, July 25th. The company reported $6.84 EPS for the quarter, beating the consensus estimate of $6.20 by $0.64. HCA Healthcare had a net margin of 8.21% and a negative return on equity of 7,363.11%. The business had revenue of $18.61 billion during the quarter, compared to the consensus estimate of $18.49 billion. During the same period in the previous year, the business earned $5.50 earnings per share. The company's revenue was up 6.4% on a year-over-year basis. HCA Healthcare has set its FY 2025 guidance at 25.500-27.000 EPS. Equities research analysts forecast that HCA Healthcare, Inc. will post 24.98 earnings per share for the current fiscal year.

HCA Healthcare Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 30th. Shareholders of record on Tuesday, September 16th will be given a dividend of $0.72 per share. This represents a $2.88 annualized dividend and a yield of 0.7%. The ex-dividend date is Tuesday, September 16th. HCA Healthcare's payout ratio is currently 12.11%.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.